p53 mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance

Cancer Journal

Volumn 6, Issue 5, 2000, Pages 302-308

  Laframboise, S ^a   Chapman, W ^a   McLaughlin, J ^a   Andrulis, I L ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Epithelial ovarian cancer; Immunohistochemistry; P53; Paclitaxel; Sequencing

Indexed keywords

PACLITAXEL; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; DISEASE RESISTANCE; DNA DAMAGE; DNA SEQUENCE; EPITHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CISPLATIN; CODON; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; EXONS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PACLITAXEL; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033763955     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chemotherapy in ovarian carcinoma: Present role and future prospects
2. Cydophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
3. Tumor suppressor genes
4. p53 gene mutations and protein accumulation in human ovarian cancer
5. Overexpression and mutation of p53 in epithelial ovarian cancer
6. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma
7. p53 Aterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: A molecular and immunohistochemical study
8. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel
9. Direct sequencing from touch preparations of human carcinomas: Analysis of p53 mutations in breast carcinomas
10. Multiptex PCR-SSCP for simultaneous screening for mutations in several exons of p53
11. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
12. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas
13. Value of Pglycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas
14. p53 gene mutations inside and outside of exons 5-8: The patterns differ in breast and other cancers
15. Molecular genetic characterization of BRCA1 and BRCA2-1 linked hereditary ovarian cancers
16. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
17. Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturate gel dectrophoresis, and hydroxylamine and osmium tetroxide techniques
18. Quantification of p53 in epithelial ovarian cancer